Drug Trial Radar · NCT05667454
MAD Trial: Myopia Atropine Dose
Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
550
Planned (sponsor's estimate)
Start
Dec 19, 2022
Primary completion
Apr 24, 2029
Study completion Apr 24, 2029
Sponsor
- Lead sponsor
- Erasmus Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ZonMw: The Netherlands Organisation for Health Research and Development
- First posted
- Dec 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this interventional study is to compare the efficacy of Atropine 0.05% to Atropine 0.5% treatment against progression of axial length in European children with progressive myopia, and to evaluate the safety, adherence, and reasons for nonresponse. Subjects will use Atropine eye drops for a period of 3 years, followed by a 2 year observational period.
Conditions
- Progressive Myopia
Interventions
Atropine Ophthalmic 0.05%Drug
Atropine 0.05% sulphate ophthalmic solution
Atropine Ophthalmic 0.5%Drug
Atropine 0.5% sulphate ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression of axial length in mm from baseline to t = 36 months.Time frame: 3 years
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Flevoziekenhuis
Almere Stad, Netherlands
OLVG, locatie Oost
Amsterdam, Netherlands
Ophthalmologistenpraktijk Delfland
Delft, Netherlands
Reinier de Graaf Gasthuis
Delft, Netherlands
Deventer Ziekenhuis
Deventer, Netherlands
Albert Schweitzer ziekenhuis
Dordrecht, Netherlands
Bergman Clinics - Ede
Ede, Netherlands
Admiraal de Ruyter Ziekenhuis
Goes, Netherlands
Frisius MC
Heerenveen, Netherlands
Oogcentrum Noordholland
Heerhugowaard, Netherlands
Leiden University Medical Center
Leiden, Netherlands
Bergman Clinics - Lelystad
Lelystad, Netherlands
Maastricht UMC+
Maastricht, Netherlands
St. Antonius
Nieuwegein, Netherlands
Radboudumc
Nijmegen, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Haga Ziekenhuis
The Hague, Netherlands
Oogkliniek Den Haag
The Hague, Netherlands
Ziekenhuis Rivierenland Tiel
Tiel, Netherlands
Elisabeth-TweeSteden Ziekenhuis
Tilburg, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.